| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/01/2010 | WO2010072741A1 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREFOR |
| 07/01/2010 | WO2010072740A2 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF |
| 07/01/2010 | WO2010072691A1 Antibodies against tissue factor pathway inhibitor |
| 07/01/2010 | WO2010072687A1 Antibodies against tissue factor pathway inhibitor (tfpi) |
| 07/01/2010 | WO2010072384A1 ANTI-IDIOTYPE ANTIBODY AGAINST AN ANTIBODY AGAINST THE AMYLOID β PEPTIDE |
| 07/01/2010 | WO2010072381A1 Immunoglobulin purification |
| 07/01/2010 | WO2010071986A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |
| 07/01/2010 | WO2010054167A3 Limited proteolysis of cd2ap and progression of renal disease |
| 07/01/2010 | WO2010053990A3 Crhr2 peptide agonists and uses thereof |
| 07/01/2010 | WO2010047830A3 Agents for hcv treatment |
| 07/01/2010 | WO2010046337A3 Ligands that have binding specificity for dc-sign |
| 07/01/2010 | WO2010041892A9 Novel application of aimp1 polypeptide |
| 07/01/2010 | WO2010037864A3 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 07/01/2010 | WO2010035292A8 The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections |
| 07/01/2010 | WO2010030653A3 Nurr1 interacting protein (nuip) |
| 07/01/2010 | WO2010028306A3 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 07/01/2010 | WO2010027818A3 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use |
| 07/01/2010 | WO2010024704A4 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 07/01/2010 | WO2010022145A3 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function |
| 07/01/2010 | WO2010002478A3 Glycopeptide and uses thereof |
| 07/01/2010 | WO2009129538A3 Human equivalent monoclonal antibodies engineered from nonhuman variable regions |
| 07/01/2010 | US20100169992 Fgfr4 antibodies |
| 07/01/2010 | US20100168400 Superagonistic Anti-CD28 Antibodies |
| 07/01/2010 | US20100168399 Antibodies that bind b7l-1 |
| 07/01/2010 | US20100168398 Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom. |
| 07/01/2010 | US20100168397 Therapeutic use of anti-cs1 antibodies |
| 07/01/2010 | US20100168396 Novel Branchiostoma Derived Fluorescent Proteins |
| 07/01/2010 | US20100168395 Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin |
| 07/01/2010 | US20100168394 Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 07/01/2010 | US20100168393 Antibody Polypeptide Libray Screening and Selected Antibody Polypeptides |
| 07/01/2010 | US20100168392 Expression of full length igg and secretion into the culture medium of prokaryotic cells |
| 07/01/2010 | US20100168382 Neuroplastin derived peptides |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
| 07/01/2010 | US20100167957 Methods for producing active scfv antibodies and libraries therefor |
| 07/01/2010 | US20100167942 Compositions, Methods and Related Uses for Cleaving Modified DNA |
| 07/01/2010 | US20100167411 Novel slc17-type transporter protein in mammal and use thereof |
| 07/01/2010 | US20100167395 Humanized GM-CSF antibodies |
| 07/01/2010 | US20100167393 Modified human thymic stromal lymphopoietin |
| 07/01/2010 | US20100167374 Ultra-fast chromatography |
| 07/01/2010 | US20100167333 Heavy Metal Binding Compounds and Their Method of Use |
| 07/01/2010 | US20100167314 Control of intracellular target molecule by ip3 receptor-binding protein |
| 07/01/2010 | US20100167313 Anti-idiotype antibody against an antibody against the amyloid beta peptide |
| 07/01/2010 | US20100167290 Molecule attachment to nanoparticles |
| 07/01/2010 | US20100167285 Methods and agents for evaluating inflammatory bowel disease, and targets for treatment |
| 07/01/2010 | US20100167040 Identification of a novel type of sucrose synthase and use thereof in fiber modification |
| 07/01/2010 | US20100166800 Recombinant attenuated clostridium organisms and vaccine |
| 07/01/2010 | US20100166797 Gammaretrovirus associated with cancer |
| 07/01/2010 | US20100166792 Antigenic Polypeptides |
| 07/01/2010 | US20100166790 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 07/01/2010 | US20100166779 Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer |
| 07/01/2010 | US20100166778 Toll-Like Receptor 3 Antagonists |
| 07/01/2010 | US20100166777 Hematopoietic cells that express mosc-1 |
| 07/01/2010 | US20100166775 S100a9 interaction screening method |
| 07/01/2010 | US20100166773 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/01/2010 | US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n |
| 07/01/2010 | US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx |
| 07/01/2010 | US20100166770 Antagonists of bacterial sequences |
| 07/01/2010 | US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles |
| 07/01/2010 | US20100166768 High Affinity Human Antibodies to PCSK9 |
| 07/01/2010 | US20100166767 Engineered anti-il-23r antibodies |
| 07/01/2010 | US20100166766 Engineered anti-tslp antibody |
| 07/01/2010 | US20100166764 Anti-myostatin antibodies |
| 07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
| 07/01/2010 | US20100166759 Metallothionein-Derived Peptide Fragments |
| 07/01/2010 | US20100166758 Novel antibody molecules and nucleic acids |
| 07/01/2010 | US20100166757 Antibodies against monocyte chemotactic proteins |
| 07/01/2010 | US20100166755 Anti-egfr antibodies |
| 07/01/2010 | US20100166754 Methods and Compositions For Treating Autoimmune Diseases or Conditions |
| 07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/2010 | US20100166749 Polypeptide variants with altered effector function |
| 07/01/2010 | US20100166746 High potency recombinant antibodies, methods for producing them and use in cancer therapy |
| 07/01/2010 | US20100166745 Transferrin receptor antibodies |
| 07/01/2010 | US20100166743 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 07/01/2010 | US20100166741 Altered br-3 binding polypeptides |
| 07/01/2010 | US20100166740 contains a Fc part derived from human origin; does not bind complement factor C1q; antiinflammatory, antiarthritic, antihistamine and bronchodilator agents; asthma treatment; gene expression |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166732 Small streptococcus pyogenes antigens and their use |
| 07/01/2010 | US20100166694 Diagnostic markers of wound infection |
| 07/01/2010 | US20100166657 USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER |
| 07/01/2010 | US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody |
| 07/01/2010 | CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | CA2748357A1 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 07/01/2010 | CA2748161A1 Targeted binding agents directed to .alpha.5.beta.1 and uses thereof |
| 07/01/2010 | CA2748158A1 Targeted binding agents directed to .alpha.5.beta.1 and uses thereof |
| 07/01/2010 | CA2748149A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |
| 07/01/2010 | CA2748125A1 Egfr-homing double-stranded rna vector for systemic cancer treatment |
| 07/01/2010 | CA2748069A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 07/01/2010 | CA2746858A1 Human cgrp receptor binding proteins |
| 07/01/2010 | CA2746779A1 Anti-idiotype antibody against an antibody against the amyloid .beta. peptide |
| 07/01/2010 | CA2746330A1 Immunoglobulin variants with altered binding to protein a |
| 07/01/2010 | CA2745707A1 Immunoglobulin purification |
| 07/01/2010 | CA2745317A1 Antibodies against tissue factor pathway inhibitor |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202244A1 Method of immunological analysis for detection of antibodies against human gstt1 (anti-hgstt1) |
| 06/30/2010 | EP2202243A2 Antigen binding domains from fish |
| 06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 06/30/2010 | EP2201119A2 Advanced cervical cell screening methods |